Superbugs & Superdrugs: Optimising development in the anti-infectives market

Chaired by: Professor Ian Chopra, Professor of Microbiology, Institute of Molecular & Cellular Biology, University of Leeds

Antimicrobial resistance is continuously growing whilst the number of new drugs being developed and reaching the market are few, to say the least. Everyday, we hear news of new superbugs hitting the global community. This problem demands a fresh approach to combating resistance. So why does the pharmaceutical industry show so little interest in developing new antibiotics?

SMi’s Superbugs & Superdrugs: A focus on antimicrobials will tackle the key issues in antimicrobial resistance. We will examine the complex procedures for getting drugs through regulatory hurdles taking into account the difference in requirements in the US and EU. Dive into the R&D pipeline and inspect the novel advances in drug development. Do not miss this opportunity to find out the incentives for development and learn of the advances in the pipeline for both anti-bacterials & anti-fungals.

More speakers are listed on the conference website.